A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers
Latest Information Update: 08 Apr 2022
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary) ; Ezetimibe; Rosuvastatin
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Navipharm
- 22 Nov 2017 Results published in the International Journal of Clinical Pharmacology and Therapeutics
- 24 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jan 2014 New trial record